RECALL ALERT: Asthma Inhaler Defect Found 

If you live with asthma, you already know how important your inhaler is.  

You depend on quick-acting medications – like Albuterol — to keep your airways relaxed and open so you can breathe easily.  

And sometimes you need this kind of relief FAST… because your life depends on it.  

But if you’re using a specific brand of Albuterol inhaler, you may not be getting the proper dosage, according to a new FDA release.  

Here’s everything you need to know about this potentially life-threatening recall.  

Earlier this month, Cipla US announced that it is voluntarily recalling six batches of Albuterol Sulfate Inhalation Aerosol 90 mcg, manufactured in November 2021.  

The recall comes after a market complaint for a single inhaler with leakage issues in the inhaler valve, which could impact the dosage amount. The defect was observed in batch number IB20056. 

But, according to the company announcement on the FDA website, the firm has recalled six batches using the same lot of valves out of an abundance of precaution. These include:  

• IB20045, 
• IB20055, 
• IB20056, 
• IB20057, 
• IB20059, 
• IB20072. 

The company also included the following risk statement. “There is a reasonable probability that failure to deliver the recommended dose to treat the respiratory symptoms of an acute asthma exacerbations such as wheezing coughing, shortness of breath and bronchospasms, due to device defect, may be life-threatening.” 

The batches were distributed across the US to retail and wholesale outlets. Cipla is notifying distributors by letter and will also arrange for returns.  

At this time, no adverse events have been reported for Albuterol Sulfate Inhalation Aerosol 90 mcg related to this recall. 

If you are currently using an Albuterol inhaler, be sure to check to see if it’s affected by this recall.  

Any recalled products should be returned to the place of purchase immediately.